Articles Tagged With: sars-cov-2
-
Myopathy Is Associated with Post-COVID-19 Fatigue
Prolonged fatigue after COVID-19 infection may be associated with evidence of myopathy, based on physical examination, electromyography, and muscle biopsy.
-
Two-Dose Novavax Added to List of U.S. COVID-19 Vaccines
The FDA issued an emergency use authorization for the fourth vaccine.
-
Outpatient Management of COVID-19
The COVID-19 pandemic continues to be a major public health concern. The availability of new therapies, as well as their use, continues to be shrouded in confusion. This discussion provides a brief clinical overview of COVID-19, followed by a focus on outpatient management and therapy based on our current understanding and available therapies.
-
An Epic Battle: SARS-CoV-2 vs. the Human Immune System
Penny Moore, PhD, an HIV researcher for about two decades, has redeployed much of her research to measure humoral immune response to SARS-CoV-2 infection and vaccination.
-
Long COVID Patients Report Symptoms 15 Months Later
Brain fog, dizziness, and more side effects can linger for many months after initial SARS-CoV-2 infection.
-
ACC Publishes Guidance on Managing Cardiovascular Ailments Post-COVID Infection
Expert panel created document to help clinicians manage patients with myocarditis and other long COVID problems associated with SARS-CoV-2.
-
Prevalence of Acute Myocarditis Related to COVID-19 Vaccination and SARS-CoV-2
Acute myocarditis is a diagnosis that has had a significant rise in prevalence and is the center of many recent discussions in the medical literature. Much of this recent increase has been secondary to SARS-CoV-2 and the COVID-19 vaccines. Amid the global SARS-CoV-2 pandemic, acute myocarditis has become much more prevalent in patients where it was previously a rare pathology. As a result of this outbreak, it has become a disease entity necessitating new and ever evolving clinical guidelines.
-
Urgent Need for ‘Universal’ Vaccines for SARS-CoV-2
There is an emerging consensus in the scientific community that is two-fold: COVID-19 is not going away anytime soon, and continuous vaccine boosters eventually could yield diminishing returns. What is needed are new, second-generation vaccines that confer broader immunity against both circulating variants and mutations yet to arise.
-
APIC Sets New Strategic Priorities Amid COVID-19
Like other healthcare workers, infection preventionists have been overwhelmed in the churning waves of the SARS-CoV-2 pandemic. An unpublished survey conducted by the Association for Professionals in Infection Control and Epidemiology and The Ohio State University School of Nursing revealed a “startling” level of stress and burnout.
-
Myocarditis, with a Focus on Cases Associated with COVID-19 and Vaccination
This article, will focus on the epidemiology, pathophysiology, presentation, diagnosis, and treatment of acute myocarditis, especially as it relates to SARS-CoV-2 and the COVID-19 mRNA vaccines.